Tyra Biosciences, Inc. (TYRA) Operating income 2020–2025
Tyra Biosciences, Inc. (TYRA) annual operating income history from SEC filings — each fiscal year as reported.
-$132.8MFY2025 · since FY2020: -$9.3M → -$132.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.8M | -27.4% |
| FY2024 | -$104.2M | -30.3% |
| FY2023 | -$79.9M | -35.7% |
| FY2022 | -$58.9M | -124.2% |
| FY2021 | -$26.3M | -182.8% |
| FY2020 | -$9.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TYRA financial trends
TYRA RevenueTYRA Net incomeTYRA Net marginTYRA Gross profitTYRA Gross marginTYRA Operating marginTYRA Operating cash flowTYRA Free cash flowTYRA Capital expendituresTYRA Return on equityTYRA Stock buybacksTYRA Dividends paidTYRA Total assetsTYRA Total liabilitiesTYRA Shareholders’ equityTYRA overview →